Menu UF Health Home Menu
 

Drugs and Therapy Bulletin

Drugs & Therapy Bulletin is a monthly publication by the Department of Pharmacy Services and the Pharmacy and Therapeutics Committee of UF Health. Each month, this newsletter highlights the most important drug topics that challenge our department.

The contents of our most recent volumes are listed below. Please click on the desired issue to view the .pdf document. For older issues, please visit our archive page.

2014 Volume 28

March, Number 2

  • Formulary Update
  • Buprenorphine Ordering at UF Health Shands Hospital
  • FDA Lifts Restrictions on Rosiglitazone (Avandia┬«)

February, Number 1

  • Formulary Update
  • Insulin Pen vs. Insulin Vial Use: Balancing the Risks

2013 Volume 27

December, Number 11

  • Formulary Update
  • Re-dosing of Reversal Agents in the Inpatient Setting

November, Number 10

  • Formulary Update
  • Patient’s Own Medication in the Inpatient Setting
  • Fearing the Fluoroquinolones
  • 2013 Annual Index

October, Number 9

  • Formulary Update
  • Oral Contraceptive Use in the Inpatient Setting
  • Resistant to Change: Antimicrobial Resistance in 2013

August/September, Number 8

  • Formulary Update
  • News: Factor in the criteria
  • A New Plan for Plan B

July, Number 7

  • Formulary Update
  • Pay for Delay (generics)
  • Editorial Change

June, Number 6

  • Formulary Update
  • How do I pronounce generic drug names?

May, Number 5

  • Formulary Update
  • The Route Less Traveled
  • High-priority, Restricted-distribution drugs

April, Number 4

  • Formulary Update
  • Formulary Categories
  • A New Online Formulary
  • Nursing’s Medication and Administration Policy

March, Number 3

  • Formulary Update
  • Why isn’t hydrocodone listed in the Formulary?
  • Alternatives when an NSAID fails?

February, Number 2

  • Formulary Update
  • Drug Dosing in Renal Impairment
  • New Drugs in 2012

January, Number 1

  • Formulary Update
  • Why we still use animal products
  • New C. difficile treatment algorithm endorsed

2012 Volume 26

November/December, Number 10

  • Formulary Update
  • Delete codeine from the Formulary?
  • Compounding pharmacies and fungal meningitis
  • 2012 Annual index

October, Number 9

  • Formulary Update
  • Oral Contraceptives and Thromboembolic Risk
  • Medication Safety Subcommittee
  • CYP2C19 Reporting Changes

August/September, Number 8

  • Formulary Update
  • Can dabigatran CAUSE clots?

July, Number 7

  • Formulary Update
  • Medicaid restricts oxycodone prescribing for children
  • Should the inpatient use of TNF-alpha drugs be restricted?

June, Number 6

  • Formulary Update
  • Don’t get burned: Use sunscreen appropriately

May, Number 5

  • Formulary Update
  • Updated pharmacokinetic consult policy
  • Mandatory Oral Hypotensive Administration Instructions
  • Anticoagulation Management at Shands at UF

April, Number 4

  • Formulary Update
  • Update on Drug Shortages
  • Is the PDR Obsolete?

March, Number 3

  • Formulary Update
  • Opioid Prescribing in “Naive”┬Ł or “Tolerant” Patients
  • Using Epic to Document Criteria for Use
  • What’s all the hype…about hyperglycemia?

February, Number 2

  • Formulary Update
  • New Drugs in 2011
  • Pardon My Language: What is PML?
  • New Personalized Medicine Subcommittee

January, Number 1

  • Formulary Update
  • Three Routes of Acetaminophen:
    Three Ways to Achieve the Same Result
  • Cardiovascular Drug-Induced DM

Archive

Visit Archive for Previous Issues